(Reuters) – OxyContin maker Purdue Pharma LP steered as much as $13 billion in income to the corporate’s controlling Sackler household, in response to U.S. states opposing efforts to halt lawsuits alleging the corporate and its house owners helped gasoline the U.S. opioid epidemic.

FILE PHOTO: A bottle of prescription painkiller OxyContin, 40mg tablets, made by Purdue Pharma L.D. sit on a counter at an area pharmacy, in Provo, Utah, U.S., April 25, 2017. REUTERS/George Frey/File Photograph

The rich Sacklers obtained the cash from Purdue throughout an unspecified time-frame, in response to court docket paperwork and parts of a deposition filed within the drugmaker’s…



Source link